טוען...
(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus
BACKGROUND: People with type 1 diabetes mellitus (T1DM) need treatment with insulin for survival. Whether any particular type of (ultra‐)long‐acting insulin provides benefit especially regarding risk of diabetes complications and hypoglycaemia is unknown. OBJECTIVES: To compare the effects of long‐t...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2021
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094220/ https://ncbi.nlm.nih.gov/pubmed/33662147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013498.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|